Aspirus Cancer Care - James Beck Cancer Center — Rhinelander, Wisconsin

Aspirus Cancer Care - James Beck Cancer Center is a clinical research site located in Rhinelander, Wisconsin, United States 54501.

Crixeo Health Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

Aspirus Cancer Care - James Beck Cancer Center has participated in 97 clinical trials with 88 currently active.

Therapeutic areas: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Extensive Stage Lung Small Cell Carcinoma.

Sponsors: National Cancer Institute (NCI), SWOG Cancer Research Network, NRG Oncology.

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Aspirus Cancer Care - James Beck Cancer Center?

Aspirus Cancer Care - James Beck Cancer Center has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Aspirus Cancer Care - James Beck Cancer Center conducted?

Aspirus Cancer Care - James Beck Cancer Center has 97 clinical trials on record, with 88 currently active. Their work covers Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Extensive Stage Lung Small Cell Carcinoma.

Is Aspirus Cancer Care - James Beck Cancer Center accredited by Crixeo Health?

Yes — Aspirus Cancer Care - James Beck Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Aspirus Cancer Care - James Beck Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.